After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Contineum Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Contineum Therapeutics Inc is $100.38M. A total of 0.14 million shares were traded on the day, compared to an average of 141.44K shares.
In the most recent transaction, Lorrain Daniel S. sold 1,010 shares of CTNM for 16.02 per share on Nov 25 ’24. After the transaction, the Chief Scientific Officer now owns 168,562 company shares. In a previous transaction on Nov 18 ’24, Lorrain Daniel S. sold 6,190 shares at 16.38 per share. CTNM shares that Chief Scientific Officer owns now total 169,572.
Among the insiders who bought shares, DANIEL LORRAIN acquired of 26,370 shares on Nov 18 ’24 at a per-share price of $17.21.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CTNM has a high of $21.92 and a low of $3.35.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CTNM’s latest balance sheet shows that the firm has $69.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.91M in debt and $3.67M in liabilities at the time. Its Book Value Per Share was $7.14, while its Total Shareholder’s Equity was -$70.89M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTNM is Buy with a score of 4.83.
